ADURO BIOTECH INC's ticker is ADRO and the CUSIP is 00739L101. A total of 86 filers reported holding ADURO BIOTECH INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,086,000 | -20.4% | 470,227 | -5.5% | 0.07% | -34.5% |
| Q1 2020 | $1,364,000 | +262.8% | 497,857 | +56.2% | 0.11% | +242.4% |
| Q4 2019 | $376,000 | +375.9% | 318,734 | +326.1% | 0.03% | +371.4% |
| Q3 2019 | $79,000 | -34.2% | 74,796 | -4.1% | 0.01% | -36.4% |
| Q2 2019 | $120,000 | -60.5% | 77,962 | +2.1% | 0.01% | -62.1% |
| Q1 2019 | $304,000 | +125.2% | 76,330 | +49.1% | 0.03% | +45.0% |
| Q4 2018 | $135,000 | – | 51,207 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 2,106,734 | $40,807,000 | 12.39% |
| Rock Springs Capital Management LP | 415,000 | $8,039,000 | 0.65% |
| CLOUGH CAPITAL PARTNERS L P | 592,697 | $11,481,000 | 0.50% |
| NJ State Employees Deferred Compensation Plan | 53,300 | $1,032,000 | 0.22% |
| Orbimed Advisors | 1,065,522 | $20,639,000 | 0.21% |
| Point72 Asset Management, L.P. | 845,700 | $16,381,000 | 0.13% |
| LMCG INVESTMENTS, LLC | 244,382 | $4,734,000 | 0.10% |
| EverPoint Asset Management, LLC | 150,000 | $2,906,000 | 0.08% |
| M&T BANK CORP | 566,560 | $10,974,000 | 0.08% |
| GLOBEFLEX CAPITAL L P | 15,200 | $294,000 | 0.06% |